ETIDIOH - NEW

Posts

Showing posts with the label pandemic influenza

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Feb. 28 '26)

Arch Virol KOBAYASHI D, Hiono T, Adachi R, Igarashi M, et al Length and density of alpha2-3 sialyllactose-containing chains on glycopolymers determine receptor binding of avian influenza viruses. Arch Virol. 2026;171:100. PubMed PARK SH, Lee SH, Seo YR, Kim DJ, et al Evolution and spread of H8Nx avian influenza viruses from wild birds in East Asia, 2019-2024. Arch Virol. 2026;171:95. PubMed Abstract available NAVEED A The bovine mammary gland as a crucible for zoonotic influenza virus emergence: Receptor-mediated adaptation of HPAI H5N1 clade 2.3.4.4b. Arch Virol. 2026;171:89. PubMed Biochem Biophys Res Commun SINGH VA, Nehul S, Saha A, Singh V, et al Bioengineered chimeric VLPs targeting chikungunya virus and SARS-CoV-2 show high immunogenicity in mice. Biochem Biophys Res Commun. 2026;805:153346. PubMed ...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Feb. 21 '26)

Antiviral Res WRONSKI S, Obernolte H, Schaudien D, Braun A, et al Prophylactic intranasal administration of bacterial lysate OM-85 mitigates human rhinovirus (RV-A1b) lung infection and inflammation in mice. Antiviral Res. 2026;247:106362. PubMed Abstract available HEDSKOG C, Rodriguez L, Hu Y, Li J, et al SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19. Antiviral Res. 2026 Jan 19:106351. doi: 10.1016/j.antiviral.2026.106351. PubMed Abstract available RODRIGUEZ L, Hu Y, Li J, Han D, et al SARS-CoV-2 Resistance Analyses From the Phase 3 OAKTREE Study of Obeldesivir in Low-Risk Nonhospitalized Participants With COVID-19. Antiviral Res. 2025 Dec 29:106339. doi: 10.1016/j.antiviral.2025.106339. PubMed Abstract available Arch Virol LIM KS, Selvan ME, Ea CK...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Feb. 7 '26)

Antimicrob Agents Chemother LLORENTE J, Sempere J, Llamosi M, Perez-Garcia C, et al Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain. Antimicrob Agents Chemother. 2025 Dec 31:e0153025. doi: 10.1128/aac.01530. PubMed Abstract available J Infect Dis VILLAFUERTE D, Fall A, Akin E, Werner AP, et al Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization. J Infect Dis. 2026 Feb 4:jiag069. doi: 10.1093. PubMed Abstract available Pediatrics GAGO CM, Ruggiero CF, Gundewar A, Rose W, et al Parent Perspectives on the Interactive Role of Charitable and Federal Nutrition Assistance. Pediatrics. 2026 Jan 6:e2025072664. doi: 10.1542/peds.2025-072664. PubMed Abstract available SALTHOUSE AL, Tann...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 31 '26)

Am J Med CHENG Y, Ling Y, Scholten J, Atkins D, et al Patterns and trends in prevalent central nervous system stimulant use in US veterans with traumatic brain injury. Am J Med. 2026;139:170-180. PubMed Abstract available BMC Pediatr AKAR A Rare disease mimicking multisystem inflammatory syndrome in children. BMC Pediatr. 2025;26:56. PubMed Abstract available Cell PEKAR JE, Crespo-Bellido A, Lemey P, Bowman AS, et al Can H5N1 avian influenza in dairy cattle be contained in the US? Cell. 2026 Jan 23:S0092-8674(25)01483-7. doi: 10.1016/j.cell.2025. PubMed Abstract available J Clin Microbiol XU X, Hull W, Plunkett D, Tu ZJ, et al Emergence of influenza A(H3N2) subclade K in northeast Ohio in autumn 2025. J Clin Microbiol. 2026 Jan 27:e0181325. doi: 10.1128/jcm.01813. PubMed J Infect Dis ZHONG...

#Development of pre-pandemic #influenza candidate #vaccine viruses for use in vaccine manufacturing

Abstract Influenza A viruses continually pose pandemic threats, underscoring the need for timely development of Candidate Vaccine Viruses (CVVs) that meet regulatory expectations for vaccine manufacturing. This protocol describes the procedures used at CDC to generate recombinant CVVs through reverse genetics in accordance with World Health Organization guidelines and CDC’s internal Quality System Requirements (QSR)1,2,3. The QSR incorporates relevant principles from the FDA’s Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) regulations, providing a structured framework that ensures documentation integrity, material traceability, and quality oversight during all stages of CVV development. The protocol provides detailed steps for plasmid preparation , virus rescue in Vero cells , and amplification in embryonated chicken eggs , and outlines characterization assays used to confirm the suitability and safety attributes of each CVV. This standardized, quality-drive...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 24 '26)

Ann Intern Med SACKS HS In older adults, RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease vs. no vaccine. Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-05113. PubMed Abstract available SOUMARE A, Kapfer T, Botrel T, Adda L, et al Systemic Corticosteroids, Mortality, and Infections in Pneumonia and Acute Respiratory Distress Syndrome : A Systematic Review and Meta-analysis. Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-03055. PubMed Abstract available Arch Virol LAI QR, Chen W, Yu GF, Guo YJ, et al Molecular epidemiology and clinical characteristics of human adenovirus in children in Hangzhou (2022-2023). Arch Virol. 2026;171:60. PubMed Abstract available Biochem Biophys Res Commun WU X, Bhatt V, Liu JJ, Hong L, et al Single-cell RNA sequencing data analysis reveals differential expr...